Number of the records: 1
Use of RLI-15 a clinical grade fusion protein with IL-15 superagonistic activity for the activation of anti-tumor immune response
- 1.
SYSNO 0521311 Title Use of RLI-15 a clinical grade fusion protein with IL-15 superagonistic activity for the activation of anti-tumor immune response Author(s) Adkins, I. (CZ)
Sadílková, I. (CZ)
Hradilová, N. (CZ)
Tomala, Jakub (MBU-M) RID, ORCID
Tomalová, Barbora (MBU-M) ORCID
Kovář, Marek (MBU-M) RID, ORCID
Mikysková, R. (CZ)
Reiniš, Milan (UMG-J) [11] RID
de Martynoff, G. (FR)
Bechard, D. (FR)
Moebius, U. (CZ)
Spíšek, R. (CZ)Source Title Cancer Research. Roč. 78, 13 S (2018). - : American Association for Cancer Research Conference Annual Meeting of the American-Association-for-Cancer-Research (AACR), 14.04.2018 - 18.04.2018 Document Type Abstrakt Institutional support MBU-M - RVO:61388971 Language eng Country US Keywords RLI-15 * IL-15 * carcinoma Cooperating institutions Sotio AS, Praha (Czech Republic) Permanent Link http://hdl.handle.net/11104/0305937
Number of the records: 1